Suppliers in Manalapan, NJ
11 Medicare Suppliers found. Showing 1 - 11
 Essential Steps Inc Medicare Supplier Location: 200 Craig Rd, Manalapan, New Jersey 07726 Phone: (732) 423-3222 |
Cvs Pharmacy #02508 Durable Medical Equipment & Medical Supplies Location: 253 Gordons Corner Rd, Manalapan, New Jersey 07726 Phone: (732) 536-0400 |
Cvs Pharmacy #05461 Durable Medical Equipment & Medical Supplies Location: 120 Woodward Rd, Manalapan, New Jersey 07726 Phone: (732) 446-0138 |
Cvs Pharmacy #16542 Durable Medical Equipment & Medical Supplies Location: 55 Us Highway 9, Manalapan, New Jersey 07726 Phone: (732) 294-5197 |
Wegmans Pharmacy #095 Durable Medical Equipment & Medical Supplies Location: 55 Us Hwy Route 9 South, Manalapan, New Jersey 07726 Phone: (732) 625-4145 |
|
First Care Medical Supplies Llc Durable Medical Equipment & Medical Supplies Location: 329 Us Highway 9, Manalapan, New Jersey 07726 Phone: (732) 303-8450 |
Walgreens #12289 Durable Medical Equipment & Medical Supplies Location: 305 Route 33, Manalapan, New Jersey 07726 Phone: (732) 851-0953 |
Walgreens #13862 Durable Medical Equipment & Medical Supplies Location: 2 Gordons Corner Rd, Manalapan, New Jersey 07726 Phone: (732) 446-1419 |
6527560001 Medicare Supplier Location: 94 Bridge Plaza Dr, Manalapan, New Jersey 07726 Phone: (732) 972-5900 |
Spare Pair Iii Vision Center Medicare Supplier Location: 357 Us Highway 9, Manalapan, New Jersey 07726 Phone: (732) 972-2221 |
News Archive
Biologic treatments to treat the physical symptoms of psoriasis
More than 4.5 million adults in the United States have been diagnosed with psoriasis and 21 percent of those have moderate to severe psoriasis. This chronic condition, characterized by thick, red, scaly plaques that itch and bleed, not only makes the activities of daily life difficult, but also can affect a person's emotional well being.
Nabi Biopharmaceuticals reports first-quarter net income of $5.5 million from continuing operations
Nabi Biopharmaceuticals today announced its first quarter financial results for the three month period ended March 27, 2010. The Company reported net income from continuing operations of $5.5 million, or $0.11 per share, compared to a net loss of $7.0 million, or $0.14 per share, for the period ended March 28, 2009.
The Children's Hospital constructs new LEED-certified patient tower
The Children's Hospital has begun the construction of a 10-story, 350,000-square-foot addition. The $230 million expansion of a new patient tower initially will have 124 beds, with two floors of shelled space for additional future beds, bringing the total number of patient beds at Children's to around 500 upon full completion. The expansion also is expected to bring approximately 500 new jobs to the hospital's workforce. Children's anticipates admitting patients in the LEED-certified tower beginning in late 2012.
Protein Sciences receives FDA approval for Flublok vaccine
The U.S. Food and Drug Administration today announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. Flublok is approved for the prevention of seasonal influenza in people 18 through 49 years of age.
› Verified 5 days ago